6OQK

SOLUTION STRUCTURE OF THE COMPLEX OF MUTANT VEK50[RH2/AA] AND PLASMINOGEN KRINGLE 2

SOLUTION NMR

---

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1.0 mM [U-99% 13C; U-99% 15N] plasminogen Kringle 2, 1.0 mM VEK50[RH2/AA], 20 mM [U-2H] Bis-Tris-d19, 2 ug/mL DSS, 2 ug/mL sodium azide	90% H2O/10% D2O	20 mM	6.8	1 atm	298	Bruker AVANCE 800
10	2D 1H-1H TOCSY	1.0 mM [U-99% 13C; U-99% 15N] plasminogen Kringle 2, 1.0 mM VEK50[RH2/AA], 20 mM [U-2H] Bis-Tris-d19, 2 ug/mL DSS, 2 ug/mL sodium azide	90% H2O/10% D2O	20 mM	6.8	1 atm	298	Bruker AVANCE 800
2	2D 1H-15N HSQC	1.0 mM [U-99% 13C; U-99% 15N] VEK50[RH2/AA], 1.0 mM plasminogen Kringle 2, 20 mM [U-2H] Bis-Tris-d19, 2 ug/mL DSS, 2 ug/mL sodium azide	90% H2O/10% D2O	20 mM	6.8	1 atm	298	Bruker AVANCE 800
11	2D 1H-1H TOCSY	1.0 mM [U-99% 13C; U-99% 15N] VEK50[RH2/AA], 1.0 mM plasminogen Kringle 2, 20 mM [U-2H] Bis-Tris-d19, 2 ug/mL DSS, 2 ug/mL sodium azide	90% H2O/10% D2O	20 mM	6.8	1 atm	298	Bruker AVANCE 800
3	3D CBCA(CO)NH	1.0 mM [U-99% 13C; U-99% 15N] VEK50[RH2/AA], 1.0 mM plasminogen Kringle 2, 20 mM [U-2H] Bis-Tris-d19, 2 ug/mL DSS, 2 ug/mL sodium azide	90% H2O/10% D2O	20 mM	6.8	1 atm	298	Bruker AVANCE 800
4	3D C(CO)NH	1.0 mM [U-99% 13C; U-99% 15N] plasminogen Kringle 2, 1.0 mM VEK50[RH2/AA], 20 mM [U-2H] Bis-Tris-d19, 2 ug/mL DSS, 2 ug/mL sodium azide	90% H2O/10% D2O	20 mM	6.8	1 atm	298	Bruker AVANCE 800
5	3D C(CO)NH	1.0 mM [U-99% 13C; U-99% 15N] VEK50[RH2/AA], 1.0 mM plasminogen Kringle 2, 20 mM [U-2H] Bis-Tris-d19, 2 ug/mL DSS, 2 ug/mL sodium azide	90% H2O/10% D2O	20 mM	6.8	1 atm	298	Bruker AVANCE 800
9	3D HNCO	1.0 mM [U-99% 13C; U-99% 15N] VEK50[RH2/AA], 1.0 mM plasminogen Kringle 2, 20 mM [U-2H] Bis-Tris-d19, 2 ug/mL DSS, 2 ug/mL sodium azide	90% H2O/10% D2O	20 mM	6.8	1 atm	298	Bruker AVANCE 800
8	3D HNCA	1.0 mM [U-99% 13C; U-99% 15N] VEK50[RH2/AA], 1.0 mM plasminogen Kringle 2, 20 mM [U-2H] Bis-Tris-d19, 2 ug/mL DSS, 2 ug/mL sodium azide	90% H2O/10% D2O	20 mM	6.8	1 atm	298	Bruker AVANCE 800
7	3D HNCACB	1.0 mM [U-99% 13C; U-99% 15N] VEK50[RH2/AA], 1.0 mM plasminogen Kringle 2, 20 mM [U-2H] Bis-Tris-d19, 2 ug/mL DSS, 2 ug/mL sodium azide	90% H2O/10% D2O	20 mM	6.8	1 atm	298	Bruker AVANCE 800
12	3D NOESY	1.0 mM [U-99% 13C; U-99% 15N] plasminogen Kringle 2, 1.0 mM VEK50[RH2/AA], 20 mM [U-2H] Bis-Tris-d19, 2 ug/mL DSS, 2 ug/mL sodium azide	90% H2O/10% D2O	20 mM	6.8	1 atm	298	Bruker AVANCE 800

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	800

NMR Refinement
Method	Details	Software
simulated annealing		X-PLOR NIH
simulated annealing		HADDOCK

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	200
Conformers Submitted Total Number	10
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin		Bruker Biospin
2	processing	TopSpin		Bruker Biospin
3	data analysis	Sparky		Goddard
4	structure calculation	CS-ROSETTA		Shen, Vernon, Baker and Bax
5	refinement	X-PLOR NIH		Schwieters, Kuszewski, Tjandra and Clore
6	refinement	HADDOCK		Bonvin